Tumor Growth Rate Estimates Are Independently Predictive of Therapy Response and Survival in Recurrent High-Grade Serous Ovarian Cancer Patients.
Bartl T, Karacs J, Kreuzinger C, Pfaffinger S, Kendler J, Ciocsirescu C, Wolf A, Reinthaller A, Meyer E, Brandstetter M, Postl M, Langthaler E, Braicu E, Vergote I, Cunnea P, Gourley C, Schmitt WD, Cacsire Castillo-Tong D, Christoph G.
Bartl T, et al. Among authors: christoph g.
Cancers (Basel). 2021 Mar 3;13(5):1076. doi: 10.3390/cancers13051076.
Cancers (Basel). 2021.
PMID: 33802395
Free PMC article.